Healthcare provider profile · identity verified

Maya Mitchell Land, MD

Internal Medicine · SANTA ROSA, CA · NPI 1619958154

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	481	186
Levothyroxine Sodium	Levothyroxine Sodium	397	126
Amlodipine Besylate	Amlodipine Besylate	278	104
Lisinopril	Lisinopril	241	88
Losartan Potassium	Losartan Potassium	214	81
Albuterol Sulfate Hfa	Albuterol Sulfate	201	90
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	174	39
Gabapentin	Gabapentin	165	60
Hydrochlorothiazide	Hydrochlorothiazide	157	70
Metformin Hcl Er	Metformin Hcl	152	53
Metoprolol Tartrate	Metoprolol Tartrate	131	43
Trazodone Hcl	Trazodone Hcl	128	45
Fluticasone Propionate	Fluticasone Propionate	123	43
Simvastatin	Simvastatin	120	40
Sertraline Hcl	Sertraline Hcl	106	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	104	48
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	99	33
Pantoprazole Sodium	Pantoprazole Sodium	98	38
Atenolol	Atenolol	97	35
Lorazepam	Lorazepam	90	38
Alvesco	Ciclesonide	88	40
Rosuvastatin Calcium	Rosuvastatin Calcium	88	28
Alendronate Sodium	Alendronate Sodium	86	33
Omeprazole	Omeprazole	78	34
Prednisone	Prednisone	70	50
Acyclovir	Acyclovir	66	30
Tamsulosin Hcl	Tamsulosin Hcl	64	24
Jardiance	Empagliflozin	63	19
Mirtazapine	Mirtazapine	63	27
Famotidine	Famotidine	61	24
Pradaxa	Dabigatran Etexilate Mesylate	61	22
Escitalopram Oxalate	Escitalopram Oxalate	60	17
Nortriptyline Hcl	Nortriptyline Hcl	59	18
Furosemide	Furosemide	58	29
Zolpidem Tartrate	Zolpidem Tartrate	58	14
Metformin Hcl	Metformin Hcl	56	16
Temazepam	Temazepam	55	13
Triamcinolone Acetonide	Triamcinolone Acetonide	54	27
Estradiol	Estradiol	52	27
Allopurinol	Allopurinol	50	20
Spironolactone	Spironolactone	48	18
Wixela Inhub	Fluticasone Propion/Salmeterol	48	14
Amoxicillin	Amoxicillin	46	24
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Tramadol Hcl	Tramadol Hcl	46	suppressed
Potassium Chloride	Potassium Chloride	45	25
Baclofen	Baclofen	44	16
Metoprolol Succinate	Metoprolol Succinate	42	19
Bupropion Xl	Bupropion Hcl	41	12
Carvedilol	Carvedilol	41	17
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	15
Clopidogrel	Clopidogrel Bisulfate	39	14
Fluocinonide	Fluocinonide	38	21
Hydrocortisone	Hydrocortisone	38	17
Duloxetine Hcl	Duloxetine Hcl	37	14
Cephalexin	Cephalexin	36	28
Doxycycline Monohydrate	Doxycycline Monohydrate	35	24
Finasteride	Finasteride	35	14
Ondansetron Hcl	Ondansetron Hcl	35	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	13
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Meloxicam	Meloxicam	32	17
Pregabalin	Pregabalin	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	12
Terazosin Hcl	Terazosin Hcl	31	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	25
Montelukast Sodium	Montelukast Sodium	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Glipizide	Glipizide	29	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	28	28
Metronidazole	Metronidazole	28	17
Spiriva Respimat	Tiotropium Bromide	28	suppressed
Lovastatin	Lovastatin	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	14
Ondansetron Odt	Ondansetron	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Retin-A	Tretinoin	26	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	25	12
Celecoxib	Celecoxib	25	suppressed
Ozempic	Semaglutide	23	suppressed
Ibuprofen	Ibuprofen	22	13
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Betamethasone Valerate	Betamethasone Valerate	21	suppressed
Buprenorphine	Buprenorphine	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	13
Glipizide Er	Glipizide	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Colchicine	Colchicine	20	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Nystatin	Nystatin	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Lactulose	Lactulose	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Testosterone	Testosterone	18	suppressed
Topiramate	Topiramate	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Epinephrine	Epinephrine	13	suppressed
Humulin N	Insulin Nph Human Isophane	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Eliquis	Apixaban	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Digoxin	Digoxin	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Pimecrolimus	Pimecrolimus	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error